Use of the prognostic biomarker suPAR in the emergency department improves risk stratification but has no effect on mortality: a cluster-randomized clinical trial (TRIAGE III)
Abstract Background Risk stratification of patients in the emergency department can be strengthened using prognostic biomarkers, but the impact on patient prognosis is unknown. The aim of the TRIAGE III trial was to investigate whether the introduction of the prognostic and nonspecific biomarker: so...
Main Authors: | Martin Schultz, Line Jee Hartmann Rasmussen, Malene H. Andersen, Jakob S. Stefansson, Alexander C. Falkentoft, Morten Alstrup, Andreas Sandø, Sarah L. K. Holle, Jeppe Meyer, Peter B. S. Törnkvist, Thomas Høi-Hansen, Erik Kjøller, Birgitte Nybo Jensen, Morten Lind, Lisbet Ravn, Thomas Kallemose, Theis Lange, Lars Køber, Lars Simon Rasmussen, Jesper Eugen-Olsen, Kasper Karmark Iversen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-08-01
|
Series: | Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13049-018-0539-5 |
Similar Items
-
Availability of suPAR in emergency departments may improve risk stratification: a secondary analysis of the TRIAGE III trial
by: Martin Schultz, et al.
Published: (2019-04-01) -
Early Discharge from the Emergency Department Based on Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels: A TRIAGE III Substudy
by: Martin Schultz, et al.
Published: (2019-01-01) -
suPAR is associated with risk of future acute surgery and post-operative mortality in acutely admitted medical patients
by: Jeppe Meyer, et al.
Published: (2018-02-01) -
Elevated suPAR Is an Independent Risk Marker for Incident Kidney Disease in Acute Medical Patients
by: Esben Iversen, et al.
Published: (2020-06-01) -
Healthy lifestyles reduce suPAR and mortality in a Danish general population study
by: Thomas Huneck Haupt, et al.
Published: (2019-01-01)